Kaneka Corporation

Kanegafuchi Kagaku Kogyo Kabushiki Kaisha

Hideyuki Kishida

Kenji Fujii

Takahiro Ueda

Shiro Kitamura

Kozo Yamamoto

Takayoshi Hidaka

Yoshihide Fuse

Ikuo Katsumi

Takashi Ueda

Mikio Kitahara

Tatsumasa Mae

Shinsuke Akao

Yasuyoshi Ueda

Kazunori Hosoe

Toshiaki Miwa

Mitsuaki Kitano

Kaku Nakagawa

Misuzu Tsukagawa

Taizo Kawabe

Shinichi Yokota

Toshinori Ikehara

Hozumi Tanaka

Minpei Kuroda

Yoshihiro Mimaki

Yutaka Sashida

Naoko Yasuhara

Toru Ota

Yuji Tominaga

Masayasu Kitagawa

Hiroshi Tachi

Yoshiyuki Shinagawa

Taizou Kawabe

The present invention provides a particulate composition wherein an oil component containing reduced coenzyme Qis polydispersed forming a domain in a matrix containing a water-soluble excipient, which simultaneously shows high oxidative stability and high oral absorbability, a production method thereof, and a stabilizing method thereof. It also provides a food, food with nutrient function claims, food for specified health uses, dietary supplement, nutritional product, animal drug, drink, feed, pet food, cosmetic, pharmaceutical product, therapeutic drug, prophylactic drug and the like, which contain the composition.

[object Object]

The present invention aims to provide a DPP-4 inhibitor that is obtained by using a food as a raw material and that is suitable for oral ingestion from the viewpoints of flavor and absorbability, and a composition for the prevention and/or amelioration of diabetes which contains the DPP-4 inhibitor. The present invention provides a DPP-4 inhibitor obtained by treating an azuki bean or a kidney bean with a microorganism or a proteolytic enzyme produced by the microorganism. In particular, a preferable DPP-4 inhibitor can be obtained by hydrolyzing an azuki bean with a koji mold or a proteolytic enzyme derived from the koji mold to fragment a protein in the azuki bean.

Dipeptidyl peptidase-4 inhibitor

Composition containing reduced coenzyme Q10 and production method thereof

A coenzyme Q-containing water soluble composition comprises coenzyme Q, a hydrophilic polyglycerol fatty acid ester, a lipophilic sucrose fatty acid ester and an aqueous phase component and a process for producing the same are disclosed. A coenzyme Q-containing water-soluble dry powder can be obtained by drying the above-mentioned coenzyme Q-containing water soluble composition. A food, functional food, beverage, pharmaceutical product, quasi drug, cosmetic, or animal food can be obtained by using the above-mentioned coenzyme Q-containing water soluble composition or the above-mentioned coenzyme Q-containing water-soluble dry powder. The coenzyme Q-containing water soluble composition has a high bioavailability, and maintains a stable emulsion form for a long period of time from refrigeration temperature to room temperature and allows efficient supply.

A composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension, which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a turmeric extract, a clove extract, and a cinnamon extract.

Compositions for preventing or ameliorating multiple risk factor syndromes

The present invention provides a reduced coenzyme Qcrystal with excellent stability and a composition containing said reduced coenzyme Qcrystals. According to the present invention, after dissolving reduced coenzyme Qin a fat and oil, it is cooled, making it possible to obtain reduced coenzyme Qcrystals with excellent stability and which exhibit an x-ray diffraction pattern (using a CuK&#x3b1; emission line) that differs from ordinary reduced coenzyme Qcrystals. Moreover, said crystals are also excellent in bioabsorbability.

Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal

The object of the present invention is to provide PPAR&#x3b3; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&#x3b3; ligand as an active agent. The present invention relates to a ligand for peroxisome proliferator-activated receptor The composition according to the present invention, which comprises the PPAR&#x3b3; ligand as an active agent is useful for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity.

Ligand for peroxisome proliferator-activated receptor

Cognition enhancing quinuclidine compound

Phenoxybenzene derivative

Growing community of inventors

Kakogawa, Japan

Hideyuki Kishida